NCT02329600View on ClinicalTrials.gov

Evaluation of Green Tea as Antioxidant Agent in Management of Oral Lichen Planus

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

October 31, 2014

Conditions
Oral Lichen Planus
Interventions
DRUG

green tea tablets (Green tea extract 5:1) 200 mg

Green tea is a product made from the Camellia sinensis plant. The fresh leaves are used to make medicine. the green tea extract is presented in a form of tablets 200 mg and is taken orally.

DRUG

Triamcinolone Acetonide

topical corticosteroids (Kenalog in orabase: Bristol-Myers, Squibb, Spain) applied topically 4 times a day i.e. following each meal and at bed time for one month

All Listed Sponsors
lead

Cairo University

OTHER

NCT02329600 - Evaluation of Green Tea as Antioxidant Agent in Management of Oral Lichen Planus | Biotech Hunter | Biotech Hunter